Latest AI and machine learning research in chemotherapy for healthcare professionals.
BACKGROUND: Postoperative nausea and vomiting (PONV) prolongs hospitalization and reduces patient satisfaction. Identifying high-risk elderly patients requires accurate absolute risk assessments, yet existing tools often lack probability calibration and transparency. METHODS: We included 1216 elderly patients undergoing elective hip or knee surgery. To strictly prevent data leakage, the dataset wa...
PURPOSE: High-risk stage II colorectal cancer (CRC) shows heterogeneous outcomes despite adjuvant chemotherapy. We developed and validated an interpretable multimodal deep learning model integrating clinical data, serum biomarkers, and venous-phase CT to predict 5-year CRC-specific mortality in high-risk stage II CRC. METHODS: This retrospective, multicenter cohort included 778 high-risk stage II ...
Osteosarcoma typically arises during adolescence, posing a significant challenge. Despite comprehensive treatment strategies encompassing surgery, rad...
BACKGROUND: Accurate evaluation of skin lesions is an essential component of dermatological examination, yet it can be time-consuming and subject to i...
BACKGROUND: This study sought to develop an innovative body composition (BC)-based deep learning (DL) model to precisely evaluate survival in gastric ...
BACKGROUND/AIM: Chemotherapy with gemcitabine and cisplatin remains the cornerstone of treatment for advanced urothelial carcinoma (UC), yet response ...
BACKGROUND: Breast cancer is a significant public health burden. Despite its critical role in preventing the recurrence of breast cancer, rates of lon...
The shift from the traditional empirical approach to a more data-driven method in the diagnosis and treatment of GI cancers is significant due to adva...
OBJECTIVE: Microsatellite instability (MSI) has emerged as a key predictive biomarker for chemotherapy and immunotherapy response, and as a prognostic...
Chemotherapy is essential for cancer treatment but may cause adverse events requiring emergency department visits and hospitalizations, placing substa...
In adjuvant research, which has long relied on experience and trial and error, advancements in technologies in broad areas, including artificial intel...
Targeting programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) with immune checkpoint inhibitors (ICIs) has...
BACKGROUND: Neoadjuvant therapy is crucial for locally advanced gastric cancer (LAGC), yet response varies significantly. Traditional models based on ...
BACKGROUND: Electrolyte abnormalities following chemotherapy are common and clinically significant complications in cancer patients and are often asso...
Age is a well-known risk factor to develop severe viral respiratory infections, including severe COVID-19. This study aimed to identify the biological...
Radiotherapy (RT) remains a cornerstone of cancer management but is fundamentally constrained by normal tissue toxicity, intrinsic and acquired radior...
Leptospirosis is difficult to diagnose because of protean nonspecific clinical manifestations and the lack of rapid, actionable laboratory testing. A ...
BACKGROUND: Patients identified with locally advanced rectal cancer (LARC) demonstrate a varied prognosis after undergoing neoadjuvant chemoradiothera...
Immunotherapy has revolutionized hepatocellular carcinoma (HCC) management, necessitating personalized strategies in current guidelines. Despite curat...
Precision-guided therapy is imperative in the battle against pancreatic ductal adenocarcinoma (PDAC), one of the most lethal solid malignancies with l...